Abstract: Somatic cells can be reprogramed into induced pluripotent stem (iPS) cells by defined factors, which provide a powerful basis for personalized stem-cell based therapies. However, cellular reprograming is an inefficient and metabolically demanding process commonly associated with obstacles that hamper further use of this technology. Spontaneous differentiation of iPS cells cultures represents a significant hurdle that hinder obtaining high quality iPS cells for further downstream experimentation. In this study, we found that a natural compound, vitamin C, augmented pluripotency in iPS cells and reduced unwanted spontaneous differentiation during iPS cells maintenance. Gene expression analysis showed that vitamin C increased the expression of the histone demethylase JARID1A. Furthermore, through gain-and loss-of-function approaches, we show that JARID1A is a key effector in promoting pluripotency and reducing differentiation downstream of vitamin C. Our results therefore highlight a straightforward method for improving the pluripotency and quality of iPS cells; it also shows a possible role for H3K4me2/3 in cell fate determination and establishes a link between vitamin C and epigenetic regulation.
Introduction
Animal development starts with the fertilized egg undergoing a programed process of cell proliferation and differentiation that generates all cell types of an individual. This process of nuclear reprograming to pluripotent state was first achieved by the transfer of somatic cell nucleus into an enucleated egg (Wilmut et al., 1997) . More recently, Yamanaka and colleagues demonstrated that somatic cells can acquire pluripotent state after the introduction of a defined combination of transcription factors that are highly enriched in embryonic stem cells (ESCs), which were termed induced pluripotent stem (iPS) cells (Takahashi et al., 2007) . iPS cells possess the ability to differentiate into the three different germ layers, ectoderm, mesoderm and endoderm, raising the possibility of clinical application of personalized stem-cell based therapies without immune rejection or ethical concerns. Human iPS cells also provide a unique platform for studying genetic diseases in vitro (Park et al., 2008) . However, the reprograming of somatic cells to a pluripotent state is prone to errors that could impede the use of this technology (Esteban and Pei, 2012) . One important obstacle hampering the utilization of iPS cells is the spontaneous differentiation of iPS colonies (Belinsky and Antic, 2013) , which represents a significant handicap for mechanistic studies and high throughput screening, and makes bona fide colony isolation time consuming and costly. In fact, from a practical perspective, a colony with too much differentiation, should be discarded and not used for further downstream applications.
Improving the quality of iPS cells has been tackled by recent work. In one study, mild hypothermia led to decreased differentiation in ESCs and iPS cells (Belinsky and Antic, 2013) , while another study showed that vitamin C enhances the quality of somatic cell reprograming in mice and human cells (Esteban and Pei, 2012) , highlighting the possibility that further manipulation of culture conditions could improve the technology of iPS cells for regenerative medicine. Vitamin C has received a great deal of interest because of its involvement in the generation of induced pluripotent stem cells from both mouse and human somatic cells (Shi et al., 2008) . The molecular regulation network of vitamin C during reprograming seems to be quite versatile: vitamin C has been reported to improve iPS cells generation by demethylation of pluripotency markers (Esteban et al., 2010) , it was also found to be an agonist of the histone demethylase Jhdm1a/1b (Wang et al., 2011) and to keep normal Dlk1-Dio3 cluster imprinting status (Stadtfeld et al., 2012) . In addition, vitamin C inhibits activation of the NF-κB signaling (Carcamo et al., 2002 (Carcamo et al., , 2004 and decreases reactive oxygen species (ROS), protecting cells from senescence and death . Moreover, vitamin C decreases p53-p21 signaling, a barrier for iPS cells generation (Hong et al., 2009 ). The epigenetic state of a cell is determined by the unique pattern of DNA methylation and histone modifications, and is responsible for cell-and tissuespecific gene expression patterns. Reprograming must involve mechanisms responsible for changing the epigenetic status of both DNA and histones genome-wide. Interestingly, despite the fact that the acquisition of the pluripotent state during reprograming entails both DNA methylations at the promoters of somatic genes (Lister et al., 2009 ) and the DNA demethylations at the promoters of pluripotent genes, the two de novo DNA methyltransferases Dnmt3a and Dnmt3b are dispensable (Pawlak and Jaenisch, 2011) , suggesting that additional epigenetic modifiers play a relevant role.
In this study, we demonstrate that vitamin C significantly reduces the incidence of spontaneous differentiation in iPS cells, promotes pluripotency and maintains an undifferentiated state of the colonies, at least in part by facilitating the expression and function of histone demethylase JARID1A and promoting the demethylation of H3K4me2/3 histone marks.
Results

Generation of human iPS cells from adult dermal fibroblasts
Human dermal fibroblasts were transduced with retroviruses designed to express the human cDNAs encoding OCT4, SOX2, KLF4 and C-MYC genes, as previously described (Takahashi et al., 2007) . Six days after transduction, the cells were plated onto mitotically inactivated mouse embryonic fibroblasts (MEFs) which served as a feeder layer. Two days later, the medium was replaced by iPS medium supplemented with 4 ng/ml basic fibroblast growth factor (bFGF). After approximately 4 weeks, colonies that resembled iPS cells were observed. To check the stemness of the iPS cell line, the expression of core transcription factors and surface markers including octamerbinding 3/4 (OCT4), SRY-box containing gene 2 (SOX2), NANOG, stage specific embryonic antigen-3 (SSEA-3), TRA1-60 and TRA1-81 was tested using reverse transcription PCR (RT-PCR) or immunofluorescence. The results showed that the expression pattern of these pluripotency markers in the generated iPS cell line is similar to that of the well-established human ES cell line H1, furthermore, neither the iPS nor H1 cells expressed stage specific embryonic antigen-1 (SSEA-1) (Supplementary Figure 1) .
Vitamin C maintains self-renewal and colony morphology of iPS cells
To examine the effect of vitamin C on spontaneous differentiation of iPS cells and whether vitamin C is effective in maintaining pluripotency, we assessed the expression of NANOG, the expression of the pluripotency surface marker SSEA-3 as well as the expression of the stagespecific embryonic antigen (SSEA)-1, SSEA-1 can be used as a positive surface marker for mouse undifferentiated stem cells and negative surface marker for human undifferentiated stem cells. Expression is down-regulated following differentiation of murine stem cells, while the differentiation of human stem cells is accompanied by an increase in SSEA-1 expression (Draper et al., 2002; Takahashi et al., 2007) . After 7 days of culturing in the presence or absence of vitamin C, we observed that the number of iPS colonies developing spontaneous differentiation was significantly lower when the medium was supplemented with vitamin C, compared to colonies grown in basal iPS medium ( Figure 1) ; the differentiated spots were hallmarked by the loss of expression of NANOG and SSEA-3 accompanied by an increased expression of SSEA-1 ( Figure 1A and B) . Collectively, the results indicate that vitamin C promotes the maintenance of pluripotency and inhibits differentiation.
Vitamin C augments the expression of pluripotency genes
To evaluate the effect of vitamin C on the expression of pluripotency genes, we measured the relative expression levels of several pluripotency genes in iPS cells following vitamin C treatment for 7 days by qualitative real-time PCR (qRT-PCR), cells grown in basal medium were used as controls. We observed that numerous pluripotency genes (Takahashi et al., 2007) , such as OCT3/4, NANOG, growth and differentiation factor 3 (GDF3), reduced expression 1 (REX1), undifferentiated embryonic cell transcription factor 1 (UTF1) and fibroblast growth factor 4 (FGF4) showed slight but significant increase of expression in vitamin C-treated cells compared to cells grown in basal medium ( Figure 2A ). These results revealed that vitamin C may promote pluripotency gene expression and facilitate maintenance of iPSCs cells in an undifferentiated state. (A) qRT-PCR quantification of mRNA levels for pluripotency genes in iPS cells grown in basal medium (control, white) or basal medium supplemented with vitamin C (gray). Relative expression levels of target genes were determined by qRT-PCR after normalization to GAPDH as an endogenous control. Primers used for Oct3/4 specifically detect the transcript from the endogenous genes, but not from the retroviral transcript. (B) qRT-PCR quantification of mRNA levels of various differentiation markers for the three germ layers in iPS cells grown in basal medium (white) or basal medium supplemented with vitamin C (black). The data in all graphs are the average of three independent experiments, error bars represent standard deviation from the mean and values are expressed as relative to control = 1. ***p < 0.001; **p < 0.01; *p < 0.05.
Effect of vitamin C on differentiation markers
Induced pluripotent stem cells possess the ability to differentiate into the three different germ layers: ectoderm, mesoderm and endoderm. To further investigate the role of vitamin C in maintaining an undifferentiated state of iPS colonies, we used qRT-PCR to measure the mRNA levels of markers of the three germ layers following vitamin C treatment for 7 days. Cells grown in basal medium showed increased expression of forkhead box A2 (FOXA2, a marker of endoderm), α feto protein (endoderm), BRA-CHURY (mesoderm), Msh homeobox-1 (MSX1, mesoderm), microtubule-associated protein 2 (MAP2, ectoderm), and paired box 6 (PAX6, ectoderm), compared to cells supplemented with vitamin C ( Figure 2B ). Taken together, these results revealed that vitamin C decreases the expression of differentiation markers and preserves iPS colonies in an undifferentiated state.
Vitamin C promotes the demethylation of H3K4me2/me3 through JARID1A
DNA methylation and histone demethylases play a central role in the reprograming process and induction of pluripotency (Pawlak and Jaenisch, 2011) ; vitamin C is a known cofactor for multiple histone demethylases (Horton et al., 2010; Young et al., 2015) and is known to modulate gene expression of several genes (Carinci et al., 2005; Belin et al., 2010; Canali et al., 2014) . This led to the hypothesis that spontaneously differentiated colonies undergo changes in the histone methylation status which eventually abolish the acquired pluripotency status and that the presence of vitamin C might inhibit this process. To test this idea, we extracted total histones from iPS colonies untreated or treated with vitamin C and analyzed the methylation status by Western blotting using antibodies against mono-, di-and tri-methylated histones H3 at K4, K9, K27 and K36. Vitamin C reduced the levels of H3K4 me2/3 at day 7 posttreatment ( Figure 3A) , whereas other tested histone methylation marks did not change noticeably (data not shown). Upon removal of vitamin C from the culture medium, the level of H3K4 me2/3 recovered in 3 days ( Figure 3A) , indicating that the effect of vitamin C on H3K4 methylation is reversible. We then questioned which DNA demethylase(s) could be responsible for reduced DNA methylation after vitamin C treatment. To address this, we extracted total RNA from iPS colonies grown with or without vitamin C and checked for the expression levels of demethylases that are known to di-and tri-methylate H3K4 (Kooistra and Helin, 2012) . Expression analysis showed that expression of the DNA demethylase JARID1A, also known as KDM5A/RBP2, was significantly higher upon treating cells with vitamin C; the expression of some other demethylases were slightly increased after vitamin C treatment, however, this increase was not significant ( Figure 3B ). These results suggested that vitamin C influences pluripotency by removing H3K4me2/3 through modulating the expression of the histone demethylase JARID1A. JARID1A is a member of the Jumonji family of proteins and has been shown to demethylate H3K4me2/3 (Kooistra and Helin, 2012) . To analyse the role of JARID1A in maintaining pluripotency, we knocked it down using two different shRNA lentiviral vectors. Knocking down JARID1A resulted in a concomitant increase in the levels of H3K4 me2/3, in agreement with vitamin C reducing this histone mark through JARID1A ( Figure 3C ). Importantly, knocking down JARID1A also increased differentiation in the absence of vitamin C ( Figure 3D and E). This shows that JARID1A is important for maintaining a pluripotent state of iPS cells and protecting against spontaneous differentiation.
We then performed gain-of-function studies by transfecting JARID1A into the cells. Overexpressing JARID1A reduced the spontaneous differentiation in the presence (more significantly) or absence of vitamin C ( Figure 4A-C) . Our results thus suggest that JARID1A play a relevant role in vitamin C-maintenance of pluripotency.
Discussion
The reprograming of somatic cells to a pluripotent state marks the dawn of a new era in biomedical research and personalized regenerative medicine as well as disease modeling. However, the conversion of somatic cells to induced pluripotent stem cells by forced expression of defined factors is an inefficient process by which somatic cells need to overcome numerous physiological barriers to reach the pluripotent state (Esteban and Pei, 2012; Qi et al., 2015) . In recent years, some studies have revealed that vitamin C enhances the quality of somatic cell reprograming (Esteban et al., 2010; Shi et al., 2010) by modulation of signaling pathways and influencing epigenetic modification to reset the epigenome to an embryonic-like state (Wang et al., 2011) , highlighting the possibility that further manipulation of culture conditions could improve this technology for regenerative medicine and downstream applications. To this goal, we generated human iPS cells and evaluated the role of vitamin C, a common nutrient vital to human health, on the spontaneous differentiation of human iPS colonies. Our results revealed an enhanced pluripotency status and diminished spontaneous differentiation in colonies grown with vitamin C compared to colonies grown in basal medium. A hallmark of iPS cells colonies is their ability to differentiate into the three germ layers (Takahashi et al., 2007) . We show that vitamin C significantly reduces the expression of various differentiation markers, helping maintain the colonies in an undifferentiated state.
We then questioned the mechanism by which vitamin C might be promoting pluripotency and inhibiting spontaneous differentiation. Cellular reprograming involves extensive changes to the epigenetic status of DNA and histones genome-wide, in particular acquiring pluripotency involves DNA methylations at the promoters of several somatic genes a simultaneous demethylation at the promoters at pluripotent genes (Lister et al., 2009; Pawlak and Jaenisch, 2011) . This made us hypothesize that a spontaneous loss of pluripotency might involve, a 'reversal' of this process and that the effect of vitamin C may rely at least in part on its ability to enhance histone demethylase function and/or expression.
Intriguingly, it has been reported that vitamin C promotes widespread DNA CpG demethylation in human ESCs through an unknown mechanism (Chung et al., 2010) , further suggesting a link between vitamin C and epigenetic remodeling. On a separate note, it has been shown that vitamin C can modulate gene expression (Carinci et al., 2005; Belin et al., 2010; Canali et al., 2014) . In this study, we present evidence that vitamin C enhances the expression of the histone demethylase JARID1A, which is accompanied by reduced spontaneous differentiation and, as such, JARID1A knockdown in iPS cells increased spontaneous differentiation significantly. Moreover, our results show that the overexpression of JARID1A effectively reduces spontaneous differentiation and that this effect is augmented in the presence of vitamin C. At this point, we cannot exclude the possibility that vitamin C and/or JARID1A promote pluripotency through alternative mechanisms. The role of histone demethylases in cell fate decisions is well established in multiple complex contexts. For example, JMJD1A is important for OCT4 reactivation in cell-fusion-mediated reprograming (Ma et al., 2008) . Likewise, LSD1 regulates self-renewal and differentiation in human ESCs (Adamo et al., 2011) . In the same line of evidence, vitamin C has been shown to act as a cofactor for histone demethylases such as JMJD1A, which demethylates histone 3 lysine 9 (H3K9) . Recent reports have also associated vitamin C with H3K36 demethylase Kdm2b during generation of iPS cells (Wang et al., 2011) , these findings highlight the complexity of epigenetic regulation during cellular reprograming.
Collectively, our data shows that vitamin C promotes pluripotency and protects iPS cells from spontaneous differentiation. We also provide a mechanistic insight into how vitamin C exerts this function which is, at least in part, through its ability to enhance the expression of the histone demethylase JARID1A in iPS cells. This is relevant from a practical point of view because for downstream analysis, only pluripotent iPS cells with no spontaneous differentiation should be used; hence our findings provide a practical and low-cost method for reducing spontaneous differentiation in human iPSCs colonies, generating high quality pluripotent cells that can be used for downstream applications. It also serves as a basis for further investigations into the molecular networks of vitamin C during reprograming and pluripotency maintenance.
Materials and methods
Cell culture
Human dermal fibroblasts (HDF), Phoenix-AMPHO 293T, mouse embryonic fibroblasts (MEFs) and 293T cells (ATCC, Manassas, VA, USA) were maintained in Dulbecco's modified eagle medium (DMEM, Sigma, St. Louis, MI, USA) containing 10% FBS and 1% penicillin and streptomycin (Invitrogen, Carlsbad, CA, USA). For MEFs the medium were supplemented with 1 × nonessential amino acids (NEAA, Invitrogen). Mitotic inactivation of MEFs was achieved by exposing cells to 4000 rads of γ-radiation. When needed, MEF feeder cells were grown on gelatin-coated dishes, 0.1% (w:v) gelatin solution was prepared by dissolving 0.1 g of gelatin powder (Sigma) in 100 ml ddH 2 O and autoclaved. The solution was added to dishes, incubated for 1 h at 37°C then removed and the dishes were then used immediately. The human ES cell line H1 was obtained from the WiCell research Institute (Madison, USA). hES and iPS cells were maintained in iPS medium, composed of DMEM/F-12-GlutaMAX-I (Invitrogen) supplemented with 20% knockout serum replacement (KSR, Invitrogen), 100 μm β-mercaptoethanol (Invitrogen), 1 × NEAA and 25 ng/ml recombinant human basic fibroblast factor (bFGF, Invitrogen). The passage number of the H1 cells used ranged from 12 to 22 and the passage number of the iPS used ranged from 5 to 18. All cells were cultured at 37°C with 5% CO 2 .
For passaging, human iPS cells were washed once with PBS and then treated with 1 mg/ml collagenase IV (Invitrogen) dissolved in DMEM/F12-GlutaMAX-I. When the edges of the colonies started dissociating from the bottom, the DMEM-F12-collagenase was removed, cells were then washed with iPS medium, scraped and collected into 15 ml conical tube, colonies were left to settle by gravity. Supernatant was removed and an appropriate volume of iPS medium was added, colonies were resuspended by gently pipetting up and down to form cell clumps. Cell clumps were transferred to a new dish on MEF feeder cells. For vitamin C treatment, vitamin C (Sigma) was added to the medium at a final concentration of 50 μg/ml (Reidling et al., 2008) .
Plasmids
Plasmids used in this study were obtained from Addgene (Cambridge, MA, USA). pMXs-hOCT3/4 (Addgene, #17217) coding for the OCT3/4 gene, pMXs-SOX2 (Addgene, #17218) coding for SOX2, pMXs-hKLF4 (Addgene, #17219) coding for KLF4 and pMXs-hc-MYC (Addgene, #17220) coding for C-MYC, pcDNA3/HA-RBP2 (Addgene, #14799) coding for JARID1A. Lentiviral vectors containing shRNA sequences against JARID1A were obtained from Origene (Origene, Rockville, MD, USA). Human JARID1A was amplified from pcDNA3/HA-RBP2 and cloned into pLJM1 (Addgene, #19319).
Virus production and infection
Phoenix-AMPHO 293T cells were plated at 3 × 10 6 cells per 100 mm dish; four dishes were prepared and incubated overnight. Cells were separately transfected with 9.0 μg of each of the four plasmids (pMXs-hOCT3/4, pMXs-SOX2, pMXs-hKLF4 and pMXs-hc-MYC) using calcium phosphate. Forty-eight hours after transfection, the supernatant of transfected cells was collected as the first virus-containing supernatant and replaced with fresh medium, which was collected after 24 h as the second virus-containing supernatant. Human fibroblasts were seeded at 5 × 10 6 cells per 100 mm dish 1 day before transduction. The virus-containing supernatants were filtered through a 0.45 μm pore-size cellulose acetate filter (Whatman, Maidstone, UK) and supplemented with 4 ug/ml polybrene (Sigma). Equal volumes of supernatants containing each of the four retroviruses were combined together, transferred to the fibroblast dish, and incubated overnight. Twenty-four hours after transduction, the virus-containing medium was removed and the second supernatant was added to the fibroblasts. Four days after transduction, fibroblasts were harvested by trypsinization and seeded on mitotically inactivated SNL feeder layer. Forty-eight hours later, the medium was replaced with iPSC medium supplemented with 4 ng/ml bFGF, the medium was changed daily. Thirty-five days after re-seeding on SNL feeder cells, colonies were picked and mechanically dissociated to small clamps by pipetting up and down. The cell suspension was transferred on a fresh SNL feeder layer in six-well plates. JARID1A shRNA lentiviral particles were generated similarly to retrovirus production but using pMD.G, pCMV and pRSV as packaging vectors and 293T cells for packaging.
Western blotting Immunostaining
For immunocytochemistry, cells were grown in Nunc Lab-Tek II Chamber slide system (Thermo Scientific, Waltham, MA, USA). For staining with antibodies, cells were processed as previously described (Eid et al., 2010) . Cells were fixed with PBS containing 4% formaldehyde for 15 min at room temperature. After washing with PBS, cells were treated with 0.1% Triton X-100 for 10 min at room temperature, cells were then washed with PBS and treated with 3% low-fat dry milk in PBS for 30 min at room temperature. Primary antibodies included anti-NANOG (Santa Cruz, sc-374103), anti-SSEA1 (Santa Cruz, sc-21702), anti-SSEA3 (Abcam, ab16286), anti-OCT-4 (Abcam, ab181557), anti-TRA-1-60 (Abcam, ab16288), anti-TRA-1-81 (Abcam, ab16289). Secondary antibodies used were Texas Red and FITC (Invitrogen). DNA was stained with DAPI (Sigma).
RNA isolation and qPCR
Total RNA was isolated using Trizol reagent (Invitrogen) according to manufacturer instructions. For mRNA analysis, 1 μg of total RNA was reverse transcribed using PrimeScript RT-PCR kit (Clontech, Mountain View, CA, USA) according to the manufacturer's instructions. Quantitative PCR was performed with SYBR Premix Ex Taq (Tli RnaseH Plus) (Clontech, USA) and analyzed with the LightCycler 96 Real-time PCR system (Roche, Basel, Switzerland). The reference mRNA GAPDH was used for normalizing the data. All samples were run in triplicates. Unpaired t-test was performed using GraphPad Prism version 5.04 for Windows, GraphPad Software, San Diego California USA (www.graphpad.com). Primer sequences are available upon request.
